In a patient with active variceal bleeding brought on by Systemic Lupus Erythematosusinduced Cirrhosis, a transjugular intrahepatic portosystemic shunt revision and embolization of an arterioportal fistula were performed simultaneously.
Annals of Radiology · 2022
DOI: 10.52338/aor.2022.3021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Radiology, 2022. Verfasst von Adam Swersky.
Abstract (Originalsprache)
Based on the type and severity of the shunt failure, transjugular intrahepatic portosystemic shunt (TIPS) occlusion is a frequent event that can be addressed. Arterioportal fistulas (APFs) are uncommon connections between the systemic artery and portal venous systems that can cause symptomatic portal hypertension. In this instance, we go over how to treat a patient who has variceal bleeding brought on by TIPS dysfunction that has been made more difficult by the existence of an APF. Keywords : Transjugular intrahepatic portosystemic shunt, Arterioportal fistula, Embolization, Endovascular intervention, Portal hypertension
Zitieren
APA
Swersky, A. (2022). In a patient with active variceal bleeding brought on by Systemic Lupus Erythematosusinduced Cirrhosis, a transjugular intrahepatic portosystemic shunt revision and embolization of an arterioportal fistula were performed simultaneously. Annals of Radiology. https://doi.org/10.52338/aor.2022.3021
Vancouver
Swersky A. In a patient with active variceal bleeding brought on by Systemic Lupus Erythematosusinduced Cirrhosis, a transjugular intrahepatic portosystemic shunt revision and embolization of an arterioportal fistula were performed simultaneously. Annals of Radiology. 2022. doi:10.52338/aor.2022.3021
BibTeX
@article{Swersky2022,
author = {Swersky, Adam},
title = {In a patient with active variceal bleeding brought on by Systemic Lupus Erythematosusinduced Cirrhosis, a transjugular intrahepatic portosystemic shunt revision and embolization of an arterioportal fistula were performed simultaneously},
journal = {Annals of Radiology},
year = {2022},
doi = {10.52338/aor.2022.3021}
}
EUVIMED